☆
Cell-free DNA-guided detection, surveillance, and therapeutic adaptation for breast cancer
Chengxin Li, Tsun Wai Chow, Sze Keong Tey, Ava Kwong
Biomarker Research
· Biochemistry (medical)
· 2026-11-19
☆
Irbesartan-loaded cRGD-modified PLGA nanoparticles attenuate intervertebral disc degeneration through an FGFR1-related mechanism
Xiao-Jun Yu, Ying-Guang Wang, Shan-Xi Wang, Ling-Jiang Li, Kai-Yuan Lin, Ren-Ji Wang, Rong-Jin Luo, Jian-Bin Guan, Si-Bo Wang, Liang Yan
Biomarker Research
· Biochemistry (medical)
· 2026-11-18
☆
The immune microenvironment in MDS-to-AML transformation: dynamic ecological remodeling and therapeutic implications
Zhangbiao Long, Ruiqiu Wu, Shumin Yuan, Kaibo Yang, Tianle Cheng, Bing Han, Jichun Yang
Biomarker Research
· Biochemistry (medical)
· 2026-11-18
☆
Tumor-draining lymph nodes as candidate sources of immunotherapy biomarkers in breast cancer: a multi-omics and artificial intelligence roadmap
Zheng Li, Shengbin Pei, Zheng Qu, Luxiao Zhang, Jiaxin Lu, Keyao Xian, Jing Wang, Yi Fang
Biomarker Research
· Biochemistry (medical)
· 2026-11-18
☆
Circulating biomarkers in early-stage hepatocellular carcinoma for risk stratification, diagnosis and prognosis
Elisa Monti, Marco Bella, Clara Vianello, Giuseppe Galvani, Alice Brighenti, Carla Serra, Andrea Boccatonda, Francesca Fornari
Biomarker Research
· Biochemistry (medical)
· 2026-11-18
☆
Multiscale neural and endocrine control of CD8⁺ T cell fate in cancer: from systemic physiology to local immune circuits
Tian Cheng, Xintong Li, Maoshu Yang, Xianshu Gao, Hongzhen Li, Chao Liu
Biomarker Research
· Biochemistry (medical)
· 2026-11-15
☆
Antibody–drug conjugates in hematologic malignancies: from target biology to linker–payload pharmacology and clinical evidence
Siming Zheng, Yongyi Yuan, Jinxin Dong, Hao Guo, Keshu Zhou
Biomarker Research
· Biochemistry (medical)
· 2026-11-15
☆
Circulating tRNA-derived small RNAs as cancer biomarkers: appraising the evidence by intended use and validation level
Ying Gong, Jing Wu, Chao Xiong, Chengyu Zhang, Jinmeng Lu, Yue Zheng, Xu Wu, Mingxing Li, Fukuan Du, Yu Chen, Shuai Deng, Yueshui Zhao, Meijuan Chen, Wanping Li, Xiaobing Li, Yuhong Sun, Li Gu, Fang Wang, Zhangang Xiao, Jing Shen
Biomarker Research
· Biochemistry (medical)
· 2026-11-15
☆
Primary somatosensory cortex activation aggravates rosacea-like dermatitis in a sensory nerve-dependent manner
Yiya Zhang, Tao Li, Qiuyu Yan, Xin Xiao, Yingxing Duan, Yangfan Li, Shuang Zhao, Mengting Chen, Zhili Deng, Ben Wang, Yingxue Huang, Jin Tang, Ximin Hu, Libei Liu, Zhuoer Zhang, Xinyi Deng, Hongfu Xie, Han Zhao, Ji Li
Biomarker Research
· Biochemistry (medical)
· 2026-11-15
☆
Distinct genomic landscapes of ALK-positive and ALK-negative systemic anaplastic large cell lymphomas: clinical impacts and translational significance
Rex K.H. Au-Yeung, Dennis Owusu, Veronica Russell, Yok-Lam Kwong, Jamilla Li, Carmen Lee, Harry Gill, Alvin Ip, William Choi, Jean L. Koff, David Jaye, Mette Ølgod Pedersen, Anne Ortved Gang, Cassandra Love, Jennifer R. Shingleton, Leonardo P.A. Biral, Elizabeth Thacker, Devang Thakkar, Clay Parker, Lanie Happ, Chee Leong Cheng, Jason Yong Sheng Chan, Sarah Ondrejka, Eric D. Hsi, Shaoying Li, Jie Xu, Sirpa Leppä, Ilja Kalashnikov, Magdalena Czader, Rohit Gulati, Lin Wang, Ridas Juskevicius, Mary Ann Thompson, Catalina Amador, Amy Chadburn, Andrew Evans, Jennifer Chapman-Fredricks, Juan Pablo Alderuccio, Govind Bhagat, Abner Louissaint, Yuri Fedoriw, Matthew McKinney, Chad M. McCall, Payal Sojitra, Raju Pillai, Amir Behdad, Carlos Galvez, Kikkeri N. Naresh, Sandeep S. Dave, Eric Tse
Biomarker Research
· Biochemistry (medical)
· 2026-11-15
Abstract Background Anaplastic large cell lymphoma (ALCL) comprises biologically distinct entities based on anaplastic lymphoma kinase (ALK) expression, itself a reflection of ALK rearrangement status. Even as genetic alterations have...
☆
Translational relevance of telomeric C-circles in cancer: from experimental research to potential clinical applications
Marco Folini, Sandro Pasquali, Nadia Zaffaroni
Biomarker Research
· Biochemistry (medical)
· 2026-11-15
☆
Innovative engineering strategies for T-cell engagers in solid tumors: from molecular design to clinical translation
Jiani Li, Mengmeng Zhu, Yujie Zhang, Zhanyang Gao, Cheng Qian, Juanjuan Shan
Biomarker Research
· Biochemistry (medical)
· 2026-11-15
☆
Immunometabolic and epigenetic reprogramming in inflammatory bowel disease: from mechanistic circuits to therapeutic targeting
Yi Han, Jun Yi, Xiaotong Wang, Shizhe Li, Min Chen, Junbo Xiao
Biomarker Research
· Biochemistry (medical)
· 2026-11-06
Abstract Inflammatory bowel disease (IBD) is a chronic, immune-mediated disorder of the gastrointestinal tract and an escalating global public health challenge, particularly in newly industrializing regions. Its etiology and...
☆
FGFBPs in health and tumors: emerging prognostic biomarkers and therapeutic implications
Jie Xia, Yang Xiao, Yongsheng Li, Huakan Zhao
Biomarker Research
· Biochemistry (medical)
· 2026-11-03
☆
Prognostic scores and biomarkers in hematologic malignancies: current evidence and future perspectives
Eliot McDonald, Emanuela Marcenaro, Philippe Robert, Pascal Rihet, Olivier Théodoly, Régis Costello
Biomarker Research
· Biochemistry (medical)
· 2026-10-31
☆
Targeted protein degradation in cancer: strategies for undruggable targets and progress towards clinical translation
Jinxin Tang, Zehao Cheng, Tiancheng Xie, Yan Zhuang, Hongkun Hu, Chenbei Li, Hua Wang, Chengyao Feng, Chao Tu
Biomarker Research
· Biochemistry (medical)
· 2026-10-28
☆
Adult-onset familial hemophagocytic lymphohistiocytosis has distinct genetic architecture and outcomes: a nationwide multicenter cohort study in China
Yu Li, Yuan Sun, Jie Bai, Ruohan Yang, Rong Liu, Jing Cao, Meiling Liao, Yaping Wang, Jiaxu Qi, Zebin Luo, Dao Wang, Haixia Yang, Muyuan Ji, Yunyan He, Shilin Liu, Weiyu Kong, Xue Li, Yan Han, Taoli Suo, Kai Xue, Gan Fu, Yong Zhang, Sujun Gao, Tingting Cui, Chengyi Wang, Yan Chen, Zhencang Zhou, Jia Zhang, Jingshi Wang, Fei Li, Rui Zhang, Zhao Wang
Biomarker Research
· Biochemistry (medical)
· 2026-10-28
☆
Multi-omics, multi-tissue analysis reveal role of extracellular matrix remodeling and sphingolipid homeostasis in edematous malnutrition (kwashiorkor)
Fabienne Nackers, Kirrily de Polnay, Ruben Almey, Simon Daled, Azahir Dan Djibo, Sarah De Saeger, Dieter Deforce, Maarten Dhaenens, Yannick Gansemans, Griet Glorieux, Ousmane Guindo, Benjamin Jenkins, Albert Koulman, Hans-Joerg Lang, Céline Langendorf, Debby Laukens, Christopher Mambula, Isabelle Mukagatare, Damon Parkington, Elh Ibrahim Tassiou, Wim Van Biesen, Tom Van De Wiele, Jill Van Massenhove, Filip Van Nieuwerburgh, Irène Adehossi, André Briend, Gerard Bryan Gonzales
Biomarker Research
· Biochemistry (medical)
· 2026-10-28
Abstract Background Edematous malnutrition, aka kwashiorkor, is a phenotype of severe malnutrition whose pathophysiology remains poorly understood. Methods In this case-control study, we employed plasma lipidomics, metabolomics, and...
☆
Synergistic efficacy of the EGFR inhibitor osimertinib with the XPO1 inhibitor selinexor in T-cell acute lymphoblastic leukemia
Rushuang Xu, Xiangtao Huang, Jia Liu, Yingying Shang, Na Zhang, Jiegang Xu, Shidi Cheng, Shuangnian Xu, Xi Li
Biomarker Research
· Biochemistry (medical)
· 2026-10-28
Abstract Background T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy with poor prognosis, especially in relapsed/refractory patients. Aberrant PI3K/AKT/mTOR and NOTCH1 signaling converge on c-MYC to drive...
☆
Immune checkpoints: cross-disease insights and clinical dilemmas
Yue Shu, Jia-xin Zhao, Biao-yu Guo, Yang Liu, Miao Zhou, Ning Ma, Cheng-long Zhu, Zui Zou
Biomarker Research
· Biochemistry (medical)
· 2026-10-28
☆
CD73-targeted CAR-NK cell therapy displays potent antitumor activity and translational potential in relapsed/refractory lung adenocarcinoma
Qianqian Liu, Qifei Dong, Yimei Chen, Nannan Wang, Dian Zhuang, Lihua Chen, Yanzhuo Ye, Shasha Huang, Wenzhao Zhong, Wei Kevin Zhang, Tao Xu, Jiaqi Sun, Huisheng Liu
Biomarker Research
· Biochemistry (medical)
· 2026-10-28
Abstract Background Relapsed/refractory (R/R) lung adenocarcinoma (LUAD) remains a clinical challenge with limited therapies and poor prognosis. CAR‑NK cell therapy has shown promise in solid tumors, but its efficacy is limited by both...
☆
IL-6/CD147-augmented CAR macrophages enhance the antitumor activity of CAR-T cells in solid tumor models
Mansur Dabai Salisu, Muhammad Auwal Saliu, Wei Liang, Rabiatu Bako Suleiman, Abdulrahman Ibrahim, Adeleye O. Adeshakin, Funmilayo O. Adeshakin, Maoxuan Liu, Xiaochun Wan
Biomarker Research
· Biochemistry (medical)
· 2026-10-28
☆
Contrasting molecular and pharmacodynamic signatures of response and resistance to sequential bortezomib and temozolomide in recurrent IDH-wildtype glioblastoma and grade 4 IDH-mutant astrocytoma: an exploratory interim analysis of NCT03643549 phase IB/II trial
Dorota Goplen, Mohummad Aminur Rahman, Jorunn Brekke, Andreas Waha, Leif Oltedal, Judit Haasz, Surendra Kumar, Even Birkeland, Frode Selheim, Stein Atle Lie, Martha Chekenya
Biomarker Research
· Biochemistry (medical)
· 2026-10-27
Abstract Background The revision of the WHO classification of CNS tumours now distinguishes grade 4 diffuse gliomas by their molecular features, but tailored treatment is yet to be standardised. Glioblastoma (isocitrate dehydrogenase (...
☆
Impact of SARS-CoV-2 vaccination on cancer trends: a nationwide interrupted time series study
Yewon Na, Munkhzul Radnaabaatar, Jaehun Jung
Biomarker Research
· Biochemistry (medical)
· 2026-10-22
☆
Ex vivo JAK and TNF inhibitor–modulated immune signatures guide first-line therapy selection in rheumatoid arthritis
Sagrario Corrales, Carlos Pérez-Sánchez, Tomas Cerdó, Christian Merlo, Beatriz Malvar-Fernández, Samuel García, Laura Muñoz-Barrera, Ismael Sanchez-Pareja, Lydia Formanti, Elena Moreno-Caño, Rafaela Ortega-Castro, Jerusalén Calvo, Concepción Aranda-Varela, Lourdes Ladehesa, Pilar Font, M. Carmen Abalos-Aguilera, Desirée Ruiz-Vilchez, Mª Ángeles Aguirre, Nuria Barbarroja, Marta E. Alarcon-Riquelme, Alejandro Escudero-Contreras, Chary López-Pedrera
Biomarker Research
· Biochemistry (medical)
· 2026-10-22
☆
Ubiquitin signaling in tumor-associated macrophage reprogramming: mechanisms and therapeutic opportunities in cancers
Xudong Li, Yaomei Wang, Ruochen Xu, Ziheng Qian, Meimei Yan, Mengya Gao, Zexing Liu, Yun Zhai, Lijie Wang, Yushan Cui, Lina Liu, Yongping Song, Zhilei Bian, Linping Xu, Wei Li, Baijun Fang
Biomarker Research
· Biochemistry (medical)
· 2026-10-16
☆
Persistent CAR-T donor cells contribute to mixed chimerism with cytopenia after CAR-T-bridged allo-HSCT: rescue by CAR-target-knockout DLI in three cases
Yi Liu, Zelin Wang, Yamei Wu, Xiuwen Xu, Xiaoxia Hu, Jing Pan
Biomarker Research
· Biochemistry (medical)
· 2026-10-16
☆
Targeting myeloid cell plasticity and metabolic reprogramming to alleviate T cell dysfunction and exhaustion-associated states and enhance immune checkpoint blockade therapy
Mingxing Wang, Jian Chen, Zhonghua Wu, Zhiying Wang, Zhixian Zhong, Yi Zhong
Biomarker Research
· Biochemistry (medical)
· 2026-10-16
☆
Peripheral blood CXCL1 serves as a non-invasive dynamic biomarker for intratumoral colonization of attenuated Salmonella
Leyang Wu, Liyuan Qiao, Xinyue Qiao, Wanru Wang, Chengxuan Lei, Ying Sun, Xiao Dong, Jiayi Yu, Chenyang Li, Zengzheng Du, Jing Tian, Mengyu Liu, Heng Liu, Zichun Hua
Biomarker Research
· Biochemistry (medical)
· 2026-10-16
☆
Dynamic regulation of H3K9 modifications in cancer: pathogenesis and targeted therapies
Yuanyuan Xu, Qihui Wu, Yuxiu Zhang, Jitong Zhao, Xiaodan Fu, Anqi Li, Yimin Li
Biomarker Research
· Biochemistry (medical)
· 2026-10-16